Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Advanced Materials (Deerfield Beach, Fla.)|February 11, 2026
Covalent Amorphous Alumina-Hydrogenated Graphene Materials With Integrated Proton Radiation Shielding and Energy Storage Capability for Space ElectronicsDuc Dung Nguyen, Cher Ming Tan, Chia-Chen Hsu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|September 7, 2012
Rutin, a Flavonoid That Is a Main Component of Saussurea involucrata, Attenuates the Senescence Effect in D-Galactose Aging Mouse ModelYing-Chen Yang, Hsueh-Yi Lin, Kang-Yi Su, et al.
ACS Omega|February 6, 2023
Nanodiamonds Doped with Manganese for Applications in Magnetic Resonance ImagingSrinivasu Kunuku, Bo-Rong Lin, Chien-Hsu Chen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 19, 2022
First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter AnalysisChang-Ting Lin, Po-Jung Su, Shih-Yu Huang, et al.
Sensors (Basel, Switzerland)|October 15, 2020
Innovative Head-Mounted System Based on Inertial Sensors and Magnetometer for Detecting Falling MovementsChih-Lung Lin, Wen-Ching Chiu, Ting-Ching Chu, et al.
Cancer Medicine|February 9, 2024
The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real-world multicenter analysisShih-Yu Huang, Po-Jung Su, Chang-Ting Lin, et al.
Medicine|February 7, 2023
Treatment outcomes with radium-223 in docetaxel-naïve versus docetaxel-treated metastatic castration-resistant prostate cancer patients: Real-world evidence from TaiwanPing-Chia Chiang, Po-Hui Chiang, I-Hsuan Alan Chen, et al.
Therapeutic Advances in Medical Oncology|December 17, 2024
Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitorsLiang-Yun Cheng, Po-Jung Su, Ming-Chun Kuo, et al.
BMC Cancer|September 15, 2023
The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapyTsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, et al.
The World Journal of Men'S Health|June 1, 2026
Early Prostate-Specific Antigen Dynamics as Predictors of Treatment Response and Survival Outcomes in Patients with Castration-Resistant Prostate Cancer and Bone Metastases Undergoing Radium-223 TherapyHui-Ying Liu, Chun-Yi Jen, Yin-Lun Chang, et al.
Pageof 5